Finzati - Logo
LIVN logo

LivaNova PLC

LIVN • Medical - Devices
$79.71
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$4.47B
Growth
26.8%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 5.6%Positive free cash flow · 3.18Consistent free cash flow · 5/5Manageable debt level · 0.39Healthy liquidity · 1.36
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:46 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$79.71
Change0.00%
Shares Out56.10M
Market Cap$4.47B
Enterprise Value$4.30B
52W Range47.13 - 85.76
Beta0.86
P/E23.71
P/S3.04
P/B3.37
P/FCF30.14
EV/Sales2.92

Investment DNA

How strong this company looks for long-term investors

69
out of 100
Business Quality
Margins, moat, returns
37/100
Financial Strength
Debt, cash, stability
71/100
Growth Potential
Revenue and expansion
84/100
Price Attractiveness
Cheap or expensive today
79/100
Why this score▼
Positive revenue growth · 5.6%Positive free cash flow · 3.18Consistent free cash flow · 5/5Manageable debt level · 0.39Healthy liquidity · 1.36Weak profitability

Analyst view

Analyst sentiment and price target

LIVN
Analyst sentiment
Based on 15 analyst votes · 2026-10-20
83/100
Bullish
Bullish
11
Hold
3
Bearish
1
Price Target
2026-08-07
Low
$76.00
Mean
$87.67
Median
$88.50
High
$95.00

Company Overview

IPO: 10/19/2015
Industry: Medical - Devices
P/B i: 3.37
Debt / Equity i: 0.39
Operating Margin: 14.36%
Net Margin: -17.47%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.39
Current Ratio: 1.36
Quick Ratio: 1.16
Status: Good

Insider Transactions

Recent executive and insider activity

Folli Stefano
Transaction: 08/01/2026
OTHER
Change
+6,273
Price
Not reported
Filing
08/05/2026
Type
OTHER
Zurbay Donald
Transaction: 06/15/2026
SELL
Change
-2,560
Price
Not reported
Filing
06/17/2026
Type
SELL
Zurbay Donald
Transaction: 06/15/2026
SELL
Change
-308
Price
$79.70
Filing
06/17/2026
Type
SELL